HUN — Huntsman Corporation

Is HUN overbought or oversold? Here is the current MarketMoodz read.

Basic Materials · Chemicals

Neutral As of November 17, 2026

Huntsman Corporation (HUN) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Basic Materials name (Chemicals) last closed at $9.30. The rating moved from Oversold to Neutral on November 12, 2026.

AI analysis

Huntsman Corporation (HUN) is positioned to benefit from a material merger with Olin that increases scale and creates visible synergy levers across polyurethanes, chlor‑alkali/vinyl and specialty businesses. Sector‑wide consolidation supports potential multiple expansion for combined, higher‑quality cash flows. Near‑term market conditions are relatively calm, which reduces downside from abrupt macro shocks and can allow focus on merger execution and earnings follow‑through. Key catalysts include progress on integration synergies, deleveraging trajectory and stable demand from industrial end markets. Major downside scenarios include merger delays or regulatory complications, weaker industrial demand, and volatility in feedstock/energy costs that compress margins; these risks justify a cautious stance on execution despite the structural upside.

Key factors

  • Merger with Olin to form OlinHuntsman creates scale, potential procurement synergies and cross‑business diversification that could re-rate Huntsman Corporation (HUN) relative to peers.
  • Sector consolidation in specialty and industrial chemicals supports valuation uplifts for scaled players and increases likelihood of further M&A-driven repricing.
  • Stable near‑term market tone with risk‑on lean among participants reduces forced selling risk and may support takeover/merger arbitrage flows into the name.
  • Exposure to specialty chemistries and polyurethanes provides differentiated end‑market exposure versus pure commodities, supporting margin upside if raw‑material and demand dynamics are favorable.
  • Operational integration and synergy targets, if delivered, can materially improve free cash flow and deleveraging prospects over the next 12–18 months.

Risks

  • Merger execution and regulatory risk: transaction close, integration complexity and potential remedies or divestitures could dilute near‑term benefits.
  • Cyclicality of end markets: weakness in automotive, construction or industrial capex could pressure volumes and pricing for specialty chemical products.
  • Commodity feedstock and energy price volatility can compress margins and increase input-cost uncertainty.
  • Balance sheet and leverage concerns during integration: incremental financing needs or slower deleveraging could constrain flexibility.
  • Environmental, health & safety liabilities and regulatory compliance costs are a persistent idiosyncratic risk in chemicals.
  • Limited current social sentiment and fresh financial filings in the provided window create uncertainty around near‑term market perception.

See today's live rating, score and targets

Members see the live hourly rating for HUN — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.